Fibrillin‐1 genetic deficiency leads to pathological ageing of arteries in mice

Fibrillin‐1, the major component of extracellular microfibrils that associate with insoluble elastin in elastic fibres, is mainly synthesized during development and postnatal growth and is believed to guide elastogenesis. Mutations in the fibrillin‐1 gene cause Marfan syndrome, a multisystem disorder characterized by aortic aneurysms and dissections. The recent finding that early deficiency of elastin modifies vascular ageing has raised the possibility that fibrillin‐1 deficiency could also contribute to late‐onset pathology of vascular remodelling. To address this question, we examined cardiovascular function in 3‐week‐old, 6‐month‐old, and 24‐month‐old mice that are heterozygous for a hypomorphic structural mutation of fibrillin‐1 (Fbn1$^{+/{\rm{mg}}\Delta}$ mice). Our results indicate that Fbn1$^{+/{\rm{mg}}\Delta}$ mice, particularly those that are 24 months old, are slightly more hypotensive than wild‐type littermates. Additionally, aneurysm and aortic insufficiency were more frequently observed in ageing Fbn1$^{+/{\rm{mg}}\Delta}$ mice than in the wild‐type counterparts. We also noted substantial fragmentation and decreased number of elastic lamellae in the aortic wall of Fbn1$^{+/{\rm{mg}}\Delta}$ mice, which were correlated with an increase in aortic stiffness, a decrease in vasoreactivity, altered expression of elastic fibre‐related genes, including fibrillin‐1 and elastin, and a decrease in the relative ratio between tissue elastin and collagen. Collectively, our findings suggest that the heterozygous mgΔ mutation accelerates some aspects of vascular ageing and eventually leads to aortic manifestations resembling those of Marfan syndrome. Importantly, our data also indicate that vascular abnormalities in Fbn1$^{+/{\rm{mg}}\Delta}$ mice are opposite to those induced by elastin haploinsufficiency during ageing that affect blood pressure, vascular dimensions, and number of elastic lamellae. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Y. Usson,et al.  Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. , 2010, American journal of physiology. Cell physiology.

[2]  R. Knutsen,et al.  Discrete Contributions of Elastic Fiber Components to Arterial Development and Mechanical Compliance , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Dean Y. Li,et al.  Elastin haploinsufficiency induces alternative aging processes in the aorta. , 2008, Rejuvenation research.

[4]  C. van Breemen,et al.  Mechanical and Pharmacological Approaches to Investigate the Pathogenesis of Marfan Syndrome in the Abdominal Aorta , 2008, Journal of Vascular Research.

[5]  R. Mecham,et al.  New insights into elastic fiber assembly. , 2007, Birth defects research. Part C, Embryo today : reviews.

[6]  Richard A Black,et al.  The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. , 2007, Biomaterials.

[7]  A. Dart,et al.  Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. , 2007, JAMA.

[8]  D. Judge,et al.  Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome , 2007, British journal of pharmacology.

[9]  D. Keene,et al.  Fibrillins 1 and 2 Perform Partially Overlapping Functions during Aortic Development* , 2006, Journal of Biological Chemistry.

[10]  A. Vitarelli,et al.  Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. , 2006, The American journal of cardiology.

[11]  J. Molkentin,et al.  Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart , 2005, Circulation.

[12]  D. Gros,et al.  Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.

[13]  C. Baumgartner,et al.  Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. , 2005, The Journal of thoracic and cardiovascular surgery.

[14]  Jessica Geubtner,et al.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. , 2004, The Journal of clinical investigation.

[15]  Attila Kovacs,et al.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. , 2003, The Journal of clinical investigation.

[16]  Sarah E. Bernard,et al.  Cell Adhesion to Fibrillin-1 Molecules and Microfibrils Is Mediated by α5β1 and αvβ3 Integrins* , 2003, Journal of Biological Chemistry.

[17]  M. Jacob Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[19]  K. Kivirikko,et al.  Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice , 2002, Circulation.

[20]  D. Chitayat,et al.  Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. , 2002, American journal of human genetics.

[21]  Clair Baldock,et al.  Fibrillin: from microfibril assembly to biomechanical function. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[22]  Tasuku Honjo,et al.  Fibulin-5/DANCE is essential for elastogenesis in vivo , 2002, Nature.

[23]  H. Dietz,et al.  Mouse models of genetic diseases resulting from mutations in elastic fiber proteins. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[24]  H. Dietz,et al.  Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Lewis,et al.  Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. , 1999, Circulation.

[26]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.

[27]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[28]  R. Mecham,et al.  Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. , 1998, Circulation research.

[29]  H. Dietz,et al.  Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.

[30]  C. Morris,et al.  Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. , 1997, Human molecular genetics.

[31]  G. Faury,et al.  Effect of age on the vasodilatory action of elastin peptides , 1997, Mechanisms of Ageing and Development.

[32]  S. Thibodeau,et al.  A 30 kb deletion within the elastin gene results in familial supravalvular aortic stenosis. , 1995, Human molecular genetics.

[33]  R. Mecham,et al.  Identification of an Elastin Cross-linking Domain That Joins Three Peptide Chains , 1995, The Journal of Biological Chemistry.

[34]  T W Redpath,et al.  Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. , 1995, British heart journal.

[35]  G. Belz,et al.  Elastic properties and Windkessel function of the human aorta , 1995, Cardiovascular Drugs and Therapy.

[36]  R. Jeremy,et al.  Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. , 1994, The American journal of cardiology.

[37]  C A Morris,et al.  Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. , 1994, The Journal of clinical investigation.

[38]  E. Davis Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. , 1994, Journal of cell science.

[39]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[40]  M. Leppert,et al.  A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[42]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[43]  R. Garrone,et al.  A routine method for contrasting elastin at the ultrastructural level. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  B. Baxter,et al.  Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. , 2008, Journal of vascular surgery.

[45]  Sarah E. Bernard,et al.  Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. , 2003, The Journal of biological chemistry.

[46]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[47]  Michael J Sherratt,et al.  Elastic fibres. , 2002, Journal of cell science.

[48]  G. Faury Function-structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres. , 2001, Pathologie-biologie.

[49]  B. Starcher,et al.  A role for neutrophil elastase in the progression of solar elastosis. , 1995, Connective tissue research.